| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 198.510 | 127.722 | 254.537 | 248.820 | 521.923 | 628.309 | 706.677 |
| Total Income - EUR | - | - | - | 198.539 | 128.111 | 255.204 | 248.820 | 521.938 | 628.413 | 708.226 |
| Total Expenses - EUR | - | - | - | 65.824 | 140.908 | 161.985 | 163.640 | 222.408 | 591.581 | 621.618 |
| Gross Profit/Loss - EUR | - | - | - | 132.715 | -12.797 | 93.219 | 85.181 | 299.530 | 36.833 | 86.608 |
| Net Profit/Loss - EUR | - | - | - | 130.730 | -14.072 | 90.488 | 82.991 | 294.728 | 24.764 | 71.038 |
| Employees | - | - | - | 1 | 2 | 3 | 2 | 4 | 8 | 6 |
Check the financial reports for the company - Neoderma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 1.132 | 838 | 1.942 | 44.415 | 34.882 | 26.541 | 61.521 |
| Current Assets | - | - | - | 172.681 | 127.899 | 227.520 | 327.581 | 639.970 | 670.359 | 846.073 |
| Inventories | - | - | - | 17.033 | 4.230 | 5.125 | 3.739 | 5.067 | 9.965 | 83.408 |
| Receivables | - | - | - | 151.126 | 122.986 | 217.560 | 302.402 | 599.776 | 613.881 | 64.076 |
| Cash | - | - | - | 4.522 | 683 | 4.835 | 21.440 | 35.127 | 46.513 | 698.589 |
| Shareholders Funds | - | - | - | 104.426 | 61.779 | 176.123 | 253.546 | 549.026 | 553.465 | 560.546 |
| Social Capital | - | - | - | 82 | 80 | 79 | 77 | 77 | 77 | 76 |
| Debts | - | - | - | 69.387 | 66.957 | 53.339 | 118.954 | 125.915 | 143.436 | 347.072 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Neoderma Srl